NewAmsterdam Pharma's obicetrapib lowers LDL-C in Phase 3 trials, showing promise as a CETP inhibitor. Read more on NAMS ...

This $330 smartwatch can outlast its competitors in battery life and fitness features, but may fall short on software updates ...

Investment in robotics may be substantial, but long-term benefits of automation include lower labour costs and more ...

Sea Limited (NYSE: SE) has been one of the most interesting tech companies to watch for the last few years. At one point, it ...

The Dell UtraSharp 32 4K Thunderbolt Hub Monitor is a solid value. It offers a crisp, vivid IPS Black 4K display for under $1 ...

In the Amazon biblical series 'House of David," the hero is a stone slinger with golden pipes and Goliath would put the fright into puny Thanos.

Keeping up with everything going on around baseball is tough enough in the best of times, but it's more true during Spring ...

If you want a CPU that has the floating point performance of a GPU, all you have to do is wait six or so years and the CPU ...

Nunez has an unusually short stride for a hard thrower, falls to the first base side while spinning off his landing heel and ...

HMRC, the Labour Party government's tax arm, pocketed more than £409m in interest charges alone last year, figures have shown ...

A group of experts consider the accessories from the past 100 years that changed how we carry our things — and ourselves.

Many stocks in the healthcare sector have trailed the wider markets, but are there pockets of opportunity? TD Asset Management's Ram Sampath discusses.